Cannara Biotech Inc.
LOVFF
$0.9125
$0.00610.67%
OTC PK
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | 8.60% | 20.91% | -31.21% | -460.01% | 70,054.55% |
| Total Depreciation and Amortization | -4.60% | 30.69% | 17.73% | 23.97% | 36.75% |
| Total Amortization of Deferred Charges | -- | -92.29% | -- | -- | -- |
| Total Other Non-Cash Items | 40.32% | -145.28% | -54.12% | 279.95% | 35.80% |
| Change in Net Operating Assets | 108.08% | 106.06% | 437.50% | 41.40% | -74.15% |
| Cash from Operations | 639.66% | 7.39% | 69.50% | 522.05% | 345.36% |
| Capital Expenditure | 56.44% | 73.04% | -19.09% | 33.70% | 28.42% |
| Sale of Property, Plant, and Equipment | -38.89% | -90.31% | -- | -- | -74.47% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 11.41% | -5.16% | 22.94% | -37.45% | -43.80% |
| Cash from Investing | 57.37% | 73.76% | 63.08% | 31.19% | 27.93% |
| Total Debt Issued | -80.00% | -100.00% | 46.67% | -- | -- |
| Total Debt Repaid | -14.92% | -9.79% | -415.24% | 1.62% | 8.20% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | 100.00% | -- | 84.86% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 33.64% | 43.29% | 73.22% | -48.29% | -95.28% |
| Cash from Financing | -417.61% | -51.08% | -869.23% | 45.26% | 125.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 321.53% | 363.79% | 2,165.86% | 118.84% | 69.93% |